2025 HCPCS Code Q0517
Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription oral drug, per 60-days
TAGS: approved pharmacy prescription supplying prophylaxis
| Notice | HCPCS Q0517 terminated on December 31, 2024. |
| Short Description | Supply fee hiv prep oral 60 |
| Product Note | 0129 |
| HCPCS Coverage Code | D - Special coverage instructions apply |
| HCPCS Action Code | N - No maintenance for this code |
| HCPCS Action Effective Date | January 01, 2025 |
| HCPCS Code Added Date | January 02, 2024 |
| HCPCS Pricing Indicator Code | 46 - Carrier priced (e.g., not otherwise classified, individual determination, carrier discretion, gap-filled amounts) |
| HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
| HCPCS Coverage Issues Manual Reference Section Number | |
| HCPCS Type Of Service Code | 9 - Other medical items or services |
| HCPCS Anesthesia Base Unit Quantity | 0 |
Check Similar HCPCS Codes
- Q5147 - Inj, aflibercept-ayyh, 1 mg
- Q5148 - Inj, nyposi 1 mcg
- Q5149 - Inj, aflibercept-abzv, 1 mg
- Q5150 - Inj, aflibercept-mrbb, 1 mg
- Q5151 - Inj, eculizumab-aagh, 2 mg
- Q5152 - Inj, eculizumab-aeeb, 2 mg
- Q5153 - Inj, aflibercept-yszy, 1 mg
- Q5154 - Inj, omlyclo, 5 mg
- Q5155 - Inj, aflibercept-jbvf, 1 mg
- Q5156 - Inj, tocilizumab-anoh, 1 mg
- Q5157 - Inj, denosumab-bmwo, 1 mg
- Q5158 - Inj, denosumab-bnht, 1 mg
- Q5159 - Inj, denosumab-dssb, 1 mg
- Q9001 - Chaplain assessment
- Q9002 - Chaplain counsel individu
- Q9003 - Chaplain counsel group
- Q9004 - Va whole health partner serv
- Q9950 - Inj sulf hexa lipid microsph
- Q9951 - Locm >= 400 mg/ml iodine,1ml
- Q9953 - Inj fe-based mr contrast,1ml